Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D003961:Dianhydrogalactitol / Q000627:therapeutic use* / Q000633:toxicity; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D013402:Sugar Alcohols / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D013402:Sugar Alcohols; D003961:Dianhydrogalactitol